Historical Valuation
Aehr Test Systems (AEHR) is now in the Overvalued zone, suggesting that its current forward PS ratio of 10.38 is considered Overvalued compared with the five-year average of 56.04. The fair price of Aehr Test Systems (AEHR) is between 7.59 to 22.66 according to relative valuation methord. Compared to the current price of 22.70 USD , Aehr Test Systems is Overvalued By 0.19%.
Relative Value
Fair Zone
7.59-22.66
Current Price：22.70
0.19%
Overvalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Aehr Test Systems (AEHR) has a current Price-to-Book (P/B) ratio of 5.43. Compared to its 3-year average P/B ratio of 7.29 , the current P/B ratio is approximately -25.57% higher. Relative to its 5-year average P/B ratio of 8.56, the current P/B ratio is about -36.59% higher. Aehr Test Systems (AEHR) has a Forward Free Cash Flow (FCF) yield of approximately -2.44%. Compared to its 3-year average FCF yield of -0.35%, the current FCF yield is approximately 602.07% lower. Relative to its 5-year average FCF yield of -0.80% , the current FCF yield is about 204.03% lower.
P/B
Median3y
7.29
Median5y
8.56
FCF Yield
Median3y
-0.35
Median5y
-0.80
Competitors Valuation Multiple
AI Analysis for AEHR
The average P/S ratio for AEHR competitors is 4.93, providing a benchmark for relative valuation. Aehr Test Systems Corp (AEHR.O) exhibits a P/S ratio of 10.38, which is 110.32% above the industry average. Given its robust revenue growth of -26.53%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for AEHR
1Y
3Y
5Y
Market capitalization of AEHR increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of AEHR in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is AEHR currently overvalued or undervalued?
Aehr Test Systems (AEHR) is now in the Overvalued zone, suggesting that its current forward PS ratio of 10.38 is considered Overvalued compared with the five-year average of 56.04. The fair price of Aehr Test Systems (AEHR) is between 7.59 to 22.66 according to relative valuation methord. Compared to the current price of 22.70 USD , Aehr Test Systems is Overvalued By 0.19% .
What is Aehr Test Systems (AEHR) fair value?
AEHR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Aehr Test Systems (AEHR) is between 7.59 to 22.66 according to relative valuation methord.
How does AEHR's valuation metrics compare to the industry average?
The average P/S ratio for AEHR's competitors is 4.93, providing a benchmark for relative valuation. Aehr Test Systems Corp (AEHR) exhibits a P/S ratio of 10.38, which is 110.32% above the industry average. Given its robust revenue growth of -26.53%, this premium appears unsustainable.
What is the current P/B ratio for Aehr Test Systems (AEHR) as of Jan 10 2026?
As of Jan 10 2026, Aehr Test Systems (AEHR) has a P/B ratio of 5.43. This indicates that the market values AEHR at 5.43 times its book value.
What is the current FCF Yield for Aehr Test Systems (AEHR) as of Jan 10 2026?
As of Jan 10 2026, Aehr Test Systems (AEHR) has a FCF Yield of -2.44%. This means that for every dollar of Aehr Test Systems’s market capitalization, the company generates -2.44 cents in free cash flow.
What is the current Forward P/E ratio for Aehr Test Systems (AEHR) as of Jan 10 2026?
As of Jan 10 2026, Aehr Test Systems (AEHR) has a Forward P/E ratio of 340.92. This means the market is willing to pay $340.92 for every dollar of Aehr Test Systems’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Aehr Test Systems (AEHR) as of Jan 10 2026?
As of Jan 10 2026, Aehr Test Systems (AEHR) has a Forward P/S ratio of 10.38. This means the market is valuing AEHR at $10.38 for every dollar of expected revenue over the next 12 months.